Subscribe to Newsletter

Trends & Forecasts

Discovery & Development Business Practice

Morphologically-Directed Raman Spectroscopy used for the characterization of protein aggregates in suspension

This application note explores the use of the Morphologi G3-ID for Morphologically-Directed Raman spectroscopy (MDRS) to identify and analyze contaminants including protein aggregates present in a stressed sample of lysozyme, and to compare particles held in suspension within a thin path wet cell with those collected on a filter membrane.

Manufacture Business Practice

Assessing the effect of formulation composition on spidroin charge and stability

Work performed in conjunction with Spiber Technologies, Uppsala, Sweden. Use of dynamic and electrophoretic light scattering to assess the effects of protein formulation composition

Manufacture Business Practice

Catapulted to the Top

Sitting Down With... Keith Thompson, CEO of the Cell and Gene Therapy Catapult, UK.

Discovery & Development Business Practice

The Numbers Game

Statisticians are vital in the pharma industry, but rarely do they receive public fanfare for their work. The Award for Statistical Excellence in the Pharmaceutical Industry aims to change the status quo.

Discovery & Development Business Practice

The Bright Star of Open Innovation

| Niclas Nilsson

Pharma companies are notoriously protective of their intellectual property, so it’s a big deal to open up and give knowledge away for free. Nevertheless, it is the path that LEO Pharma took with its Open Innovation platform – and they’ve learnt that, if you give a little away, you can expect much in return.

Business & Regulation Business Practice

Pharma Thieves

A new study estimates that 11.6 billion euros’ worth of goods are being stolen across Europe each year – but what about pharmaceuticals?

Business & Regulation Business Practice

Open or Closed Innovation

| Stephanie Vine

Collaboration can be the key to success, but does open innovation truly unlock the right doors?

Business & Regulation Business Practice

Deep Data Diver

Sitting Down With... Brian Overstreet, President at Advera Health Analytics, USA.

Business & Regulation Business Practice

Hail the Tattletale

Does incentivizing informants deter off-label drug marketing ? Should other countries follow suit?

Business & Regulation Business Practice

Distraction Tactics

Documents reveal that Turing and Valeant both used PR to divert attention from drug price hikes

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register